Business Wire
BusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex Times
Back to front
USAA agrees to share technology with Bank of America after years of patent litigation, report says
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 7, 12:29 PM EDT

USAA agrees to share technology with Bank of America after years of patent litigation, report says

The insurer USAA and Bank of America reached a technology-sharing arrangement following a long-running dispute over technology patents, according to a report citing the resolution of years of litigation.

USAA has reached a deal to share technology with Bank of America, ending what the report characterizes as years of legal conflict tied to technology patents. The development is reported in a business update carried by Yahoo Finance and originating from the San Antonio area, which notes that USAA has been litigious on the technology-patent front for an extended period.

The report does not provide extensive deal terms in the excerpt available for review. It does not, for example, specify what particular technologies are being licensed or shared, what the commercial economics are, or whether either party received payments as part of the settlement.

Bank of America is widely known for its role in consumer and corporate banking, as well as technology and operations that support its financial products. When technology patents and related litigation arise between large financial institutions and specialized insurers, the disputes often center on systems, software, or methods used to deliver services, rather than traditional bank lending or underwriting lines.

In this case, the key takeaway is not a change in banking strategy on the balance sheet, but a reduction in litigation and a shift toward collaboration through an agreement to share technology. Even when terms are not disclosed publicly, such resolutions can reduce uncertainty for both sides and potentially lower the ongoing costs associated with continued legal battles.

For USAA, which focuses on serving members of the U.S. military community, the resolution likely reflects the practical need to keep critical systems moving while narrowing exposure to patent-related claims. The report’s emphasis that USAA had been in repeated conflict over technology patents underscores how central that issue has been to its legal posture.

Bank of America, in turn, would benefit from any settlement that reduces the risk that patent claims could disrupt product development timelines or require costly redesigns. While the report does not state the scope of any technology coverage, a technology-sharing agreement typically implies at least some level of ongoing access to defined intellectual property or technical capabilities.

What is not clear from the available reporting is whether the agreement is limited to specific products or internal systems, whether it is reciprocal, and how long the technology sharing lasts. The report also does not indicate whether additional lawsuits were dismissed alongside the settlement or whether other related parties are involved.

Why It Matters

  • A patent-litigation settlement can reduce legal uncertainty and cost, even if the underlying commercial impact is not immediately visible in publicly reported financial results.
  • Technology-sharing arrangements may influence how quickly companies can continue or modify platform features, depending on the scope of intellectual property involved.
  • For large financial institutions, resolving IP disputes can be a announcement that parties are prioritizing execution over extended litigation.
  • Because key deal terms are not disclosed in the available reporting, investors and analysts will likely focus on any later disclosures in filings, earnings materials, or regulatory updates.

Sources

Key Facts

  • USAA reached an agreement to share technology with Bank of America, according to a report carried by Yahoo Finance and published by a San Antonio-area outlet.
  • The report links the agreement to years of lawsuits involving technology patents.
  • The available report excerpt does not detail the specific technologies at issue.
  • The report excerpt does not describe the financial terms of the deal or whether payments are included.
  • The excerpt does not specify the agreement’s duration, reciprocity, or whether additional related claims were resolved.

Finance Related

Oct 20, 1:14 PM EDT
The Apex Times

JPMorgan weighs the value of physical branches as banks compete for higher-value customers

A new stock-market analysis highlights JPMorgan Chase’s continued branch expansion, arguing that in-person presence can help win and retain customers who generate deposits, investment revenue, and loan demand. But the company has not provided detailed, publicly disclosed results tying specific branch openings to profitability or customer retention.

JPMorgan weighs the value of physical branches as banks compete for higher-value customers
The Apex Times